The combination of anastrozole and fulvestrant was more effective than anastrozole alone or sequential anastrozole and fulvestrant for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal…
Breast cancer, the second most common cause of cancer throughout the world, according to the Global Cancer Observatory, is the fourth leading cause of cancer death. In the…
Learning objectives 1. State how breast cancer is diagnosed and evaluated. 2. Identify the implications of genetics for patients with breast cancer. 3. Discuss targeted therapy for breast…
The number of new breast cancer cases is relatively stable (breast cancer represents 15% of all new cancer cases diagnosed in the United States each year), but improvements…
A friend of mine has a daughter who’s expecting her second child and was just diagnosed with breast cancer. She’s currently undergoing low-dose chemotherapy and will have a…
Through evidence-based education and shared decision-making, nurses play a vital role in closing knowledge gaps and empowering all patients at risk for breast cancer. This article focuses on…
The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for…
Women with a history of a false-positive mammogram result may be at increased risk of developing breast cancer for up to 10 years after the false-positive result, according…
On May 24, the FDA approved Piqray (alpelisib) tablets, to be used in combination with fulvestrant, to treat postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal…
On Dec. 10, the U.S. Food and Drug Administration expanded the approved use of Zytiga (abiraterone acetate) to treat men with metastatic castration-resistant prostate cancer before receiving chemotherapy.…
A study presented at the American Society of Clinical Oncology June meeting found that removing additional axillary lymph nodes to look for breast cancer in women with limited…
Efforts to fight breast cancer have been ongoing for years, and for good reason: It’s the leading second cause of cancer death in women. Men, however, frequently are…
While physicians mostly applauded a government-appointed panel’s recommendation that women get routine mammography screening for breast cancer starting at age 40, down from 50, not everyone approves. Some…
The American Cancer Society and the American Society of Clinical Oncology have released a new Breast Cancer Survivorship Care Guideline to help breast cancer survivors and their primary…
A vaccine being developed in the Mayo Clinic in Jacksonville, Florida is aimed at preventing new cases of ovarian and breast cancer and even recurring cases of these…
In 2015, Bridgett Spillers, FNP-C, was diagnosed with HER2-positive breast cancer. Bridgett recently shared a bit of her story with American Nurse Today.
Researchers have found that persistent fatigue in breast cancer survivors may be caused by disruption in the autonomic system, and could make some patients seem as much as…
More than half of older women with early stage breast cancer receive more radiation therapy than what might be medically necessary and following evidence-based guidelines for radiation would…
Low-carb diets don’t affect cardiac risk Although diets low in carbohydrates and high in fats and proteins have been popular for the last few years, some experts have…
CDC recommends annual flu shots for children ages 2 to 4 For the first time, the Centers for Disease Control and Prevention (CDC) is endorsing yearly flu shots…
Johnson & Johnson’s Campaign for Nursing’s Future In 2002, Johnson & Johnson launched the Campaign for Nursing’s Future to enhance the image of nursing, help recruit new nurses…
Breast cancer strikes 1 in 8 American women. This article discusses recent diagnostic and treatment advances (including some you may not know about) that may brighten the outlook…
The combination of anastrozole and fulvestrant was more effective than anastrozole alone or sequential anastrozole and fulvestrant for the treatment of hormone receptor-positive metastatic…
Breast cancer, the second most common cause of cancer throughout the world, according to the Global Cancer Observatory, is the fourth leading cause of…
Learning objectives 1. State how breast cancer is diagnosed and evaluated. 2. Identify the implications of genetics for patients with breast cancer. 3. Discuss…
A friend of mine has a daughter who’s expecting her second child and was just diagnosed with breast cancer. She’s currently undergoing low-dose chemotherapy…
Through evidence-based education and shared decision-making, nurses play a vital role in closing knowledge gaps and empowering all patients at risk for breast cancer.…
The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer…
On May 24, the FDA approved Piqray (alpelisib) tablets, to be used in combination with fulvestrant, to treat postmenopausal women, and men, with hormone…
On Dec. 10, the U.S. Food and Drug Administration expanded the approved use of Zytiga (abiraterone acetate) to treat men with metastatic castration-resistant prostate…
A study presented at the American Society of Clinical Oncology June meeting found that removing additional axillary lymph nodes to look for breast cancer…
While physicians mostly applauded a government-appointed panel’s recommendation that women get routine mammography screening for breast cancer starting at age 40, down from 50,…
The American Cancer Society and the American Society of Clinical Oncology have released a new Breast Cancer Survivorship Care Guideline to help breast cancer…
In 2015, Bridgett Spillers, FNP-C, was diagnosed with HER2-positive breast cancer. Bridgett recently shared a bit of her story with American Nurse Today.
Researchers have found that persistent fatigue in breast cancer survivors may be caused by disruption in the autonomic system, and could make some patients…
More than half of older women with early stage breast cancer receive more radiation therapy than what might be medically necessary and following evidence-based…
Johnson & Johnson’s Campaign for Nursing’s Future In 2002, Johnson & Johnson launched the Campaign for Nursing’s Future to enhance the image of nursing,…
Breast cancer strikes 1 in 8 American women. This article discusses recent diagnostic and treatment advances (including some you may not know about) that…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.